The use of certolizumab pegol to successfully treat generalized pustular psoriasis combined with psoriatic uveitis

J Dermatol. 2023 Jun;50(6):e175-e176. doi: 10.1111/1346-8138.16704. Epub 2022 Dec 30.

Authors

Kazuki Yatsuzuka¹, Takuya Matsumoto², Yuri Sakane³, Ryo Fukaura⁴, Takuya Takeichi⁴, Masashi Akiyama⁴, Masamoto Murakami¹

Affiliations

¹ Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan.
² Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan.
³ Department of Ophthalmology, Ehime University Graduate School of Medicine, Ehime, Japan.
⁴ Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

PMID: 36585757
DOI: 10.1111/1346-8138.16704

No abstract available

Publication types

Letter

MeSH terms

Arthritis, Psoriatic*
Certolizumab Pegol / therapeutic use
Exanthema*
Humans
Psoriasis* / complications
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Uveitis* / complications
Uveitis* / drug therapy

Substances

Certolizumab Pegol